Modern Pathology

TABLE 1

FROM:

Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors

Gordon G Wang, James C Yao, Samidha Worah, Jill A White, Rene Luna, Tsung-Teh Wu, Stanley R Hamilton and Asif Rashid

BACK TO ARTICLE

Table 1. Clinicopathologic features of patients with pancreatic endocrine, and nonileal and ileal carcinoid tumors

Clinicopathologic features Pancreatic endocrine tumors (n=16) Nonileal carcinoid tumors (n=15) Ileal carcinoid tumors (n=16)P-value a
Age (mean plusminuss.d.) (years)56.1plusminus15.959.5plusminus11.059.0plusminus13.2NSb
     
Gender
 Female56 (9)53 (8)44 (7)NS
 Male44 (7)47 (7)56 (9) 
     
History of smoking
 Current or former56 (9)67 (10)38 (6)NS
 Never44 (7)33 (5)62 (10) 
     
History of alcohol consumption
 Current or former13 (2)60 (9)44 (7)0.02c
 Never87 (14)40 (6)56 (9) 
     
Size of primary tumor (meanplusminuss.d.) (cm) 4.1plusminus2.73.3plusminus5.92.1plusminus1.0NS
     
Lymph node metastasis
 Present44 (7)53 (8)87 (12)NS
 Absent56 (9)47 (7)13 (4) 
     
Liver metastasis
 Present25 (4)27 (4)69 (11)0.02d
 Absent75 (12)73 (11)31 (5) 
     
Vital status
 Alive87 (14)87 (13)100 (16)NS
 Dead13 (2)13 (2)0 (0) 

 Values are expressed as percent and numbers in parentheses.

a Comparison among all three groups.

b Not significant, NS.

c Pancreatic endocrine tumors vs carcinoid tumors, P=0.01 for ethanol consumption.

d Nonileal carcinoid tumors vs ileal carcinoid tumors, P=0.02 for liver metastasis.

BACK TO ARTICLE